Literature DB >> 17159083

Renal denervation does not abolish sustained baroreflex-mediated reductions in arterial pressure.

Thomas E Lohmeier1, Drew A Hildebrandt, Terry M Dwyer, Austin M Barrett, Eric D Irwin, Martin A Rossing, Robert S Kieval.   

Abstract

Recent studies indicate that suppression of renal sympathetic nerve activity and attendant increments in renal excretory function are sustained baroreflex-mediated responses in hypertensive animals. Given the central role of the kidneys in long-term regulation of arterial pressure, we hypothesized that the chronic blood pressure-lowering effects of the baroreflex are critically dependent on intact renal innervation. This hypothesis was tested in 6 dogs by bilaterally activating the carotid baroreflex electrically for 7 days before and after bilateral renal denervation. Before renal denervation, control values for mean arterial pressure and plasma norepinephrine concentration were 95+/-2 mm Hg and 96+/-12 pg/mL, respectively. During day 1 of baroreflex activation, mean arterial pressure decreased 13+/-1 mm Hg, and there was modest sodium retention. Daily sodium balance was subsequently restored, but reductions in mean arterial pressure were sustained throughout the 7 days of baroreflex activation. Activation of the baroreflex was associated with sustained decreases in plasma norepinephrine concentration ( approximately 50%) and plasma renin activity (30% to 40%). All of the values returned to control levels during a 7-day recovery period. Two weeks after renal denervation, control values for mean arterial pressure, plasma norepinephrine concentration, plasma renin activity, and sodium excretion were comparable to those measured when the renal nerves were intact. Moreover, after renal denervation, all of the responses to activation of the baroreflex were similar to those observed before renal denervation. These findings demonstrate that the presence of the renal nerves is not an obligate requirement for achieving long-term reductions in arterial pressure during prolonged activation of the baroreflex.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17159083     DOI: 10.1161/01.HYP.0000253507.56499.bb

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  37 in total

Review 1.  Implantable device therapy for the treatment of resistant hypertension.

Authors:  Nikhil Joshi; Jeremy Taylor; John D Bisognano
Journal:  J Cardiovasc Transl Res       Date:  2009-03-04       Impact factor: 4.132

2.  Baroreflex device therapy in the treatment of hypertension.

Authors:  Sarada C Uppuluri; Eugene Storozynsky; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

3.  Chronic Interactions Between Carotid Baroreceptors and Chemoreceptors in Obesity Hypertension.

Authors:  Thomas E Lohmeier; Radu Iliescu; Ionut Tudorancea; Radu Cazan; Adam W Cates; Dimitrios Georgakopoulos; Eric D Irwin
Journal:  Hypertension       Date:  2016-05-09       Impact factor: 10.190

Review 4.  The baroreflex as a long-term controller of arterial pressure.

Authors:  Thomas E Lohmeier; Radu Iliescu
Journal:  Physiology (Bethesda)       Date:  2015-03

5.  Effect of baroreflex activation therapy on renal sodium excretion in patients with resistant hypertension.

Authors:  Mark Lipphardt; Michael J Koziolek; Luca-Yves Lehnig; Ann-Kathrin Schäfer; Gerhard A Müller; Stephan Lüders; Manuel Wallbach
Journal:  Clin Res Cardiol       Date:  2019-04-06       Impact factor: 5.460

Review 6.  [Baroreflex activation therapy : Indication and evidence in resistant hypertension and heart failure].

Authors:  M Wallbach; M J Koziolek; R Wachter
Journal:  Internist (Berl)       Date:  2018-10       Impact factor: 0.743

Review 7.  Lowering of blood pressure by chronic suppression of central sympathetic outflow: insight from prolonged baroreflex activation.

Authors:  Thomas E Lohmeier; Radu Iliescu
Journal:  J Appl Physiol (1985)       Date:  2012-07-12

8.  CrossTalk opposing view: Which technique for controlling resistant hypertension? Carotid sinus stimulation.

Authors:  Jens Jordan
Journal:  J Physiol       Date:  2014-09-15       Impact factor: 5.182

9.  Mechanisms of blood pressure reduction by prolonged activation of the baroreflex.

Authors:  Radu Iliescu; Thomas E Lohmeier
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

10.  Prolonged activation of the baroreflex decreases arterial pressure even during chronic adrenergic blockade.

Authors:  Thomas E Lohmeier; Drew A Hildebrandt; Terry M Dwyer; Radu Iliescu; Eric D Irwin; Adam W Cates; Martin A Rossing
Journal:  Hypertension       Date:  2009-03-09       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.